Jiaqian Fang

Jiaqian Fang

Auto-generated profile, based on publicly available information

Jiaqian Fang

Nanjing University of Chinese Medicine , Nanjing , Jiangsu Province , China , njucm.edu.cn

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
RCRui Chen
Rui Chen
JFJiaqian Fang
Jiaqian Fang
HSHairuo Sun
Hairuo Sun
ZYZhiyong Yu
Zhiyong Yu
YHYangfan Huang
Yangfan Huang
YSYaohong Song
Yaohong Song
Purpose: Macrophages play a pivotal role in the progression of atherosclerosis (AS), and targeting macrophage-associated pathological processes has emerged as a promising therapeutic strategy for AS. Flavonoids have demonstrated potent antioxidant properties with potential anti-atherosclerotic effects. This study aimed to investigate the therapeutic effects of the flavonoid calycosin-7-glucoside (CG) on AS and elucidate its underlying molecular mechanisms. Methods: Macrophages were differentiated from human monocytic THP-1 cells by treatment with phorbol-12-myristate-13-acetate (PMA). Foam cell formation was induced by exposing differentiated macrophages to oxidized low-density lipoprotein (ox-LDL). Protein and inflammatory cytokine expression levels were assessed using RT-qPCR, Western blot, and ELISA assays. Total cholesterol and free cholesterol levels were quantified using commercial kits, and lipid droplet accumulation was visualized using Nile red staining. Results: Activation of activating transcription factor 1 (ATF-1) was found to mediate CG-induced suppression of inflammatory responses and foam cell formation in ox-LDL-exposed THP-1-derived macrophages. CG treatment enhanced p38 MAPK activity, which was responsible for ATF-1 activation and subsequent inhibition of inflammation and foam cell formation. Mechanistically, ATF-1 facilitated CG-induced anti-atherosclerotic effects by upregulating liver X receptor beta (LXR-β) and cystic fibrosis transmembrane conductance regulator (CFTR), which are critical for lipid metabolism and inflammation regulation, respectively. Conclusion: CG attenuates ox-LDL-induced foam cell formation and inflammatory responses in THP-1-derived macrophages by activating the p38 MAPK/ATF-1 signaling pathway, leading to the upregulation of LXR-β and CFTR. These findings highlight the potential of CG as a therapeutic agent for AS.

1 January 2026 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
YHYangfan Huang
Yangfan Huang
ZXZhengshu Xia
Zhengshu Xia
ZYZhiyong Yu
Zhiyong Yu
JSJiaying Song
Jiaying Song
JFJiaqian Fang
Jiaqian Fang
RCRui Chen
Rui Chen
Qingxin Tongmai Yin (QXTMY), a classic traditional Chinese medicine (TCM) formula widely used for cardiovascular and cerebrovascular diseases, has unclear multitarget mechanisms against atherosclerosis (AS). This study integrated network pharmacology with experimental validation to investigate these mechanisms. Network pharmacology identified 128 bioactive compounds and 135 potential targets of QXTMY, highlighting key anti‐AS targets such as TNF, IL6, insulin (INS), IL1B, MMP9, CCL2, and ALB, with the AGE‐RAGE signaling pathway as a central mechanism; principal active ingredients included quercetin, kaempferol, luteolin, and cryptotanshinone. In vitro experiments using THP‐1‐derived macrophages induced with phorbol‐12‐myristate‐13‐acetate (PMA) and oxidized low‐density lipoprotein (ox‐LDL) showed that QXTMY significantly suppressed inflammatory responses, inhibited foam cell formation, and downregulated the AGE‐RAGE signaling pathway, as measured by Western blot, ELISA, cholesterol quantification, and Nile Red staining. These findings suggest that QXTMY may exert protective effects against AS, potentially via suppression of the AGE‐RAGE‐mediated inflammatory axis. However, in vivo validation is still required to support these preliminary conclusions.